Furthermore, Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy for CRC, and CX3CR1 is critical for Ly6Clo monocyte transmigration across the endothelium in murine CRC tumors [38]. The gene discussed is CX3CR1; the disease is cancer.